Long non-coding RNAs as new players in bladder cancer: Lessons from pre-clinical and clinical studies
The clinical management of bladder cancer (BC) has become an increasing challenge due
to high incidence rate of BC, malignant behavior of cancer cells and drug resistance. The …
to high incidence rate of BC, malignant behavior of cancer cells and drug resistance. The …
[引用][C] Long non-coding RNAs as new players in bladder cancer: Lessons from pre-clinical and clinical studies
S Mirzaei, MDA Paskeh, F Hashemi, A Zabolian… - Life Sciences, 2022 - cir.nii.ac.jp
Long non-coding RNAs as new players in bladder cancer: Lessons from pre-clinical and
clinical studies | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 …
clinical studies | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 …
Long non-coding RNAs as new players in bladder cancer: Lessons from pre-clinical and clinical studies
S Mirzaei, MDA Paskeh, F Hashemi… - Life …, 2022 - pubmed.ncbi.nlm.nih.gov
The clinical management of bladder cancer (BC) has become an increasing challenge due
to high incidence rate of BC, malignant behavior of cancer cells and drug resistance. The …
to high incidence rate of BC, malignant behavior of cancer cells and drug resistance. The …
[PDF][PDF] Long non-coding RNAs as new players in bladder cancer: Lessons from pre-clinical and clinical studies
S Mirzaei, MDA Paskeh, F Hashemi, A Zabolian… - Life …, 2022 - drive.google.com
The clinical management of bladder cancer (BC) has become an increasing challenge due
to high incidence rate of BC, malignant behavior of cancer cells and drug resistance. The …
to high incidence rate of BC, malignant behavior of cancer cells and drug resistance. The …
Long non-coding RNAs as new players in bladder cancer: Lessons from pre-clinical and clinical studies.
S Mirzaei, MDA Paskeh, F Hashemi, A Zabolian… - Life …, 2021 - europepmc.org
The clinical management of bladder cancer (BC) has become an increasing challenge due
to high incidence rate of BC, malignant behavior of cancer cells and drug resistance. The …
to high incidence rate of BC, malignant behavior of cancer cells and drug resistance. The …
Long non-coding RNAs as new players in bladder cancer: Lessons from pre-clinical and clinical studies
S Mirzaei, MDA Paskeh, F Hashemi… - Life …, 2022 - research.sabanciuniv.edu
The clinical management of bladder cancer (BC) has become an increasing challenge due
to high incidence rate of BC, malignant behavior of cancer cells and drug resistance. The …
to high incidence rate of BC, malignant behavior of cancer cells and drug resistance. The …
Long non-coding RNAs as new players in bladder cancer: Lessons from pre-clinical and clinical studies
S Mirzaei, MDA Paskeh, F Hashemi… - Life …, 2022 - research.sabanciuniv.edu
The clinical management of bladder cancer (BC) has become an increasing challenge due
to high incidence rate of BC, malignant behavior of cancer cells and drug resistance. The …
to high incidence rate of BC, malignant behavior of cancer cells and drug resistance. The …